Following heart surgery, patients commonly experience acute kidney injury (AKI) and a progressive loss of kidney function. But a Yale-led study identifies specific blood and urine markers that can predict which patients will suffer these serious complications. The findings suggest that early detection and better patient monitoring could prevent kidney deterioration. The study appears online in the Journal of the American Society of Nephrology.
- Computer Science - Sep 15 Bound for robotic glory
- Life Sciences - Sep 14 Slimy Fish and the Origins of Brain Development
- Life Sciences - Sep 14 Muscular dystrophy: Repair the muscles, not the genetic defect
- Business - Sep 12 MIT releases endowment figures for 2014
- Life Sciences - Sep 12 Project prepares collection for 21st- century challenge of invasive species
- Life Sciences - Sep 12 Stanford Professor Robert Schimke, a pioneer in biomedical sciences, dies at 81
- Life Sciences - Sep 12 Stanford’s Karl Deisseroth wins Keio Prize
- Law - Sep 12 Panel discusses the death of Michael Brown
- Literature - Sep 12 Back to School: U of’T library system ranked in top three with Harvard and Yale
- Life Sciences - Sep 12 McGill- led projects awarded Brain Canada grants
- Medicine - Sep 12 Blank GE Healthcare visit highlights partnerships in Milwaukee area
- Medicine - Sep 12 Center for Advanced Cellular Therapeutics to Rise on Penn Medicine Campus
Biomarkers assist in detecting life-threatening kidney injury after cardiac surgery
Acute kidney injury is a frequent complication of cardiac surgery that may lead to several adverse outcomes, including higher patient mortality. Previous studies have shown that several biomarkers can forecast early-onset AKI after cardiac surgery. However, most episodes of AKI are transient and will last only for a few days. Just 10 to 15 percent of patients will progress to severe AKI. Until now, there have been no effective tools to predict the risk of progressively worsening kidney function at the time of early-onset AKI.
The Yale-led research team, along with researchers from other institutions in the United States and Canada, are known as the Translational Research Investigating Biomarker End-Points in AKI consortium (TRIBE-AKI), a multidisciplinary group of academic investigators with expertise in pre-clinical, translational, epidemiologic and health services research.
The TRIBE-AKI consortium evaluated blood and urine samples of 380 cardiac surgery patients on the day they were diagnosed with AKI, and found that one blood and two urine biomarkers (blood neutrophil gelatinase-associated lipocalin, urine IL-18, and urine albumin/creatinine ratio) forecast the future progressive deterioration in kidney injury as well as adverse patient outcomes.
"Daily monitoring of these biomarkers after cardiac surgery can provide us with an earlier window to intervene in cases where patients will have continued deterioration of their kidney function after surgery," said lead author and principal investigator Chirag Parikh, M.D. Ph.D., director of the Program of Applied Translational Research and associate professor of nephrology at Yale School of Medicine and the Veterans Affairs Medical Center.
Other authors are Jay L. Koyner of the University of Chicago, Amit X. Garg and Heather Thiessen-Philbrook of the University of Western Ontario, Steven G. Coca and Kyaw Sint of Yale, Uptal D. Patel of Duke, and Michael G. Shilpak of the University of California San Francisco for the TRIBE-AKI Consortium.
Last job offers
- Pedagogy - 13.9
Gender, Women & Sexuality Studies - Associate Professor (AA8077)
- Computer Science - 13.9
Assistant Professor (2 positions)
- Administration - 13.9
Assistant Professor, Human Services (Child and Family Studies Concentration)
- History - 13.9
Assistant Professor, History (Public History)
- Medicine - 13.9
Assistant Professor of Clinical Neurosurgery
- Microtechnics - 13.9
Canada Research Excellence Chair in Smart Grids
- Medicine - 13.9
Assistant / Associate Professor
- Medicine - 12.9
Asst/Assoc / Professor of Clinical Pediatrics (Neurologist)